Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONGeneric

CEFAZOLIN SODIUM

CEFAZOLIN SODIUM

Standard Dose
EQ 5GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview CEFAZOLIN SODIUM is listed in Drugs@FDA under application 063018 (ANDA).
  • Marketing status: Discontinued Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 5GM BASE/VIAL Sponsor TEVA PHARMS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview CEFAZOLIN SODIUM is listed in Drugs@FDA under application 063018 (ANDA). Marketing status: Discontinued Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 5GM BASE/VIAL Sponsor TEVA PHARMS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.